In vitro assay by bioengineering of new antiviral drugs

被引：0
|
作者：
Tashuta, Viktor
Klestova, Zinaida
Voronina, Alla
Dgebuadze, Shota
机构：
来源：
NEW BIOTECHNOLOGY | 2014年 / 31卷
关键词：
D O I：
10.1016/j.nbt.2014.05.1888
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
PE-12
引用
收藏
页码：S113 / S114
页数：3
相关论文
共 50 条
  • [41] EVALUATION OF VARICELLA-ZOSTER ANTIVIRAL DRUGS BY A NUCLEIC-ACID HYBRIDIZATION ASSAY
    STANBERRY, LR
    MYERS, MG
    ANTIVIRAL RESEARCH, 1988, 9 (06) : 367 - 377
  • [42] High-Throughput Zika Viral Titer Assay for Rapid Screening of Antiviral Drugs
    Lee, Emily M.
    Titus, Steven A.
    Xu, Miao
    Tang, Hengli
    Zheng, Wei
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2019, 17 (03) : 128 - 139
  • [43] In Silico and In Vitro: Identifying New Drugs
    Pauli, Ivani
    Saraiva Macedo Timmers, Luis Fernando
    Caceres, Rafael Andrade
    Pereira Soares, Milena Botelho
    de Azevedo, Walter Filgueira, Jr.
    CURRENT DRUG TARGETS, 2008, 9 (12) : 1054 - 1061
  • [44] The in vitro Evaluation of the Activity of COVID-19 Antiviral Drugs Against Adenovirus
    Romanowski, Eric G.
    Yates, Kathleen A.
    Romanowski, John E.
    Shanks, Robert M. Q.
    Kowalski, Regis P.
    CLINICAL OPHTHALMOLOGY, 2021, 15 : 4787 - 4793
  • [45] Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19
    Bocci, Giovanni
    Bradfute, Steven B.
    Ye, Chunyan
    Garcia, Matthew J.
    Parvathareddy, Jyothi
    Reichard, Walter
    Surendranathan, Surekha
    Bansal, Shruti
    Bologa, Cristian G.
    Perkins, Douglas J.
    Jonsson, Colleen B.
    Sklar, Larry A.
    Oprea, Tudor, I
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2020, 3 (06) : 1278 - 1292
  • [46] SIMVASTATIN HAS SIGNIFICANT ANTIVIRAL SYNERGISM IN VITRO WITH ANTI-HBV DRUGS
    Bader, Ted
    Korba, Brent
    Bronze, Michael
    HEPATOLOGY, 2009, 50 (04) : 498A - 498A
  • [47] Druggable targets from coronaviruses for designing new antiviral drugs
    Silva, Leandro Rocha
    da Silva Santos-Junior, Paulo Fernando
    Brandao, Julia de Andrade
    Anderson, Leticia
    Bassi, Enio Jose
    de Araujo-Junior, Joao Xavier
    Cardoso, Silvia Helena
    da Silva-Junior, Edeildo Ferreira
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (22)
  • [48] New class of orthopoxvirus antiviral drugs that block viral maturation
    Byrd, CM
    Bolken, TC
    Mjalli, AM
    Arimilli, MN
    Andrews, RC
    Rothlein, R
    Andrea, T
    Rao, M
    Owens, KL
    Hruby, DE
    JOURNAL OF VIROLOGY, 2004, 78 (22) : 12147 - 12156
  • [49] Market uptake of new antiviral drugs for the treatment of hepatitis C
    Lettmeier, Beate
    Muehlberger, Nikolai
    Schwarzer, Ruth
    Sroczynski, Gaby
    Wright, Davene
    Zeuzem, Stefan
    Siebert, Uwe
    JOURNAL OF HEPATOLOGY, 2008, 49 (04) : 528 - 536
  • [50] NEW ANTIVIRAL DRUGS FOR HEPATITIS C IN ITALY: WILL IT BE A TREASURE HUNT?
    Gardini, I
    Fontana, R.
    Fumagalli, M.
    Conforti, M.
    Lanati, E. P.
    VALUE IN HEALTH, 2012, 15 (07) : A331 - A332
12345